Cystatin Like 1 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human Cystatin-like 1 (CSTL1; UniProt Q9H114), full-length 145 aa secreted protein expressed in HEK293 cells. Suited for cystatin-family activity assays, antibody validation, and reproductive biology research.
Expression system
HEK293
Cat. #
REC-CystatinLike1

In stock

SKU
REC-CystatinLike1
$498.00

Target Overview

Cystatin-like 1 (CSTL1; UniProt Q9H114) is a 145-amino-acid secreted protein belonging to the type 2 cystatin superfamily, specifically the Cres/Testatin subgroup — a reproductive-tissue-enriched cluster of cystatin-related proteins. Unlike canonical type 2 cystatins, members of this subgroup show restricted tissue expression patterns and are studied primarily in the context of reproductive tract biology. This recombinant form is produced in HEK293 mammalian cells, an expression system that supports the post-translational processing and secretory pathway handling appropriate for a natively secreted protein of this family. Full-length sequence coverage (145 residues) is used, ensuring that conformational epitopes and any functionally relevant surface features are preserved for downstream assay work. Researchers use this recombinant primarily in three contexts. First, as a positive control or calibration standard in cystatin-family protease inhibition assays — for example, to benchmark activity against cathepsin B or cathepsin L under defined substrate conditions. Second, as an antigen for antibody validation: Western blot and immunohistochemistry protocols benefit from a well-characterised recombinant standard of defined concentration and identity. Researchers selecting this recombinant for antibody validation work can pair it directly with Triple Point Biologics' matched anti-CSTL1 antibody (SKU: RP-CystatinLike1), which has been validated for Western blot against human samples. Third, the recombinant serves as a pull-down or binding partner reagent in experiments designed to identify protein–protein interactions within the cystatin superfamily or between CSTL1 and candidate protease targets. Species reactivity for validated applications is human. Cross-reactivity with non-human orthologues is predicted based on sequence conservation but has not been independently confirmed by Triple Point Biologics.

Background

Cystatin-like 1 (CSTL1) is a member of the Cres/Testatin subgroup of type 2 cystatins — a set of cystatin-superfamily genes that, unlike ubiquitously expressed family members such as cystatin C, show pronounced restriction to reproductive tissues. Frygelius et al. (2010) conducted a systematic evolutionary and expression analysis of the Cres/Testatin subgroup across mammalian species, mapping the genomic organisation of these genes and documenting their human tissue expression profiles. That work placed CSTL1 within a cluster of paralogues that likely arose through gene duplication events and diversified in function alongside reproductive-tissue specialisation. The selective expression pattern of CSTL1, encoded at its gene locus as a secreted 145-residue polypeptide (UniProt Q9H114), points toward roles in the extracellular protease environment of the reproductive tract, though its precise biochemical activity relative to classical cystatin-family cysteine-protease inhibitors remains an active area of characterisation. The broader cystatin/cathepsin axis in reproductive tissue has been examined in parallel contexts. Song et al. (2010) characterised cathepsin B, cathepsin L, and cystatin C in the porcine uterus and placenta, demonstrating that cystatin-family proteins participate in endometrial and placental remodelling and in epithelial fluid-phase protein transport across placental areolae. That work illustrates the experimental framework — protease activity assays, immunolocalisation, and biochemical fractionation — within which recombinant cystatin-family proteins, including CSTL1, serve as useful research tools. Because CSTL1 is a secreted protein, its accessibility in conditioned media and extracellular compartments makes it tractable for biochemical studies without the need for membrane solubilisation. Recombinant CSTL1 produced in HEK293 cells is well-suited to inhibition kinetics experiments designed to probe whether this family member retains the canonical cysteine-protease inhibitory function of type 2 cystatins, or whether evolutionary divergence within the Cres/Testatin subgroup has yielded a protein with altered or attenuated inhibitory capacity. Substrate profiling by mass spectrometry and surface plasmon resonance binding experiments with recombinant cathepsin family members represent natural follow-on applications. CSTL1 has also been investigated in the context of reproductive tract biology as a research target — published literature places it within a gene family whose members are studied for roles in sperm maturation, fertilisation environments, and uterine physiology. Researchers working in these areas use well-characterised recombinant preparations to establish baseline biochemical properties before advancing to cell-based or tissue-level models. Triple Point Biologics has produced antibodies against proteinase and inhibitor targets since 1994, and this recombinant is catalogued alongside the matched anti-CSTL1 antibody (RP-CystatinLike1) to support integrated protein and antibody workflows.

Applications

  • Cysteine-protease inhibition assay: testing CSTL1 inhibitory activity against recombinant cathepsin B or cathepsin L using fluorogenic substrate (e.g., Z-Phe-Arg-AMC)
  • Inhibitor IC50 determination: benchmarking small-molecule or peptide-based cystatin-pathway modulators using CSTL1 as the enzyme or inhibitor standard
  • Antibody validation positive control: Western blot and IHC verification of the matched Triple Point Biologics anti-CSTL1 antibody (RP-CystatinLike1) at defined antigen concentrations
  • ELISA standard curve generation: serial dilution of recombinant CSTL1 for quantification of endogenous CSTL1 in biological fluids or conditioned media
  • Pull-down / co-immunoprecipitation: identification of CSTL1 binding partners, including candidate cysteine proteases, using immobilised recombinant protein as bait
  • Surface plasmon resonance (SPR) or bio-layer interferometry (BLI): kinetic characterisation of CSTL1 binding affinity to protease family members
  • Substrate-specificity profiling by mass spectrometry: incubation of CSTL1 with protease substrates to map cleavage or inhibition profiles within the cystatin superfamily context

References

  1. Frygelius J et al. Evolution and human tissue expression of the Cres/Testatin subgroup genes, a reproductive tissue specific subgroup of the type 2 cystatins. Evol Dev. 2010;12(4):440–447. doi:10.1111/j.1525-142X.2010.00418.x PMID: 20565543
  2. Song G et al. Cathepsin B, cathepsin L, and cystatin C in the porcine uterus and placenta: potential roles in endometrial/placental remodeling and in fluid-phase transport of proteins secreted by uterine epithelia across placental areolae. Biol Reprod. 2010;82(5):854–864. doi:10.1095/biolreprod.109.080929 PMID: 20107207

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Secreted; extracellular fluids

Frequently Asked Questions

What is the expected molecular weight of Cystatin Like 1 (Recombinant) on SDS-PAGE?

The full-length CSTL1 sequence encodes 145 amino acids, giving a predicted unmodified MW of approximately 16.5 kDa. Because this recombinant is produced in HEK293 cells — which support N-linked glycosylation and other secretory pathway modifications — the apparent MW on reducing SDS-PAGE typically runs slightly higher, in the 18–22 kDa range depending on gel percentage and run conditions. Use a 12–15% polyacrylamide gel for cleanest resolution. Purity is confirmed >90% by SDS-PAGE prior to release.

Is Cystatin Like 1 processed or cleaved in the secretory pathway, and does the recombinant reflect the mature form?

CSTL1 carries a predicted signal peptide (approximately residues 1–20) that directs it into the secretory pathway. In HEK293 expression, the signal peptide is cleaved co-translationally, so the secreted recombinant protein represents the mature processed form beginning around residue 21. Full-length sequence coverage of all 145 residues is used in the construct design, ensuring the signal sequence is present for correct processing. Researchers working with tissue-derived CSTL1 can therefore use this recombinant as a direct molecular weight and immunoreactivity reference.

Does Cystatin Like 1 inhibit cysteine proteases like papain or cathepsin B, and what assay substrate should I use?

Like other type 2 cystatin superfamily members, CSTL1 is studied as a candidate cysteine protease inhibitor, though inhibitory potency in the Cres/Testatin subgroup is generally weaker or more context-dependent than canonical cystatins such as cystatin C. For benchmarking inhibitory activity, a standard fluorogenic substrate assay using Z-Phe-Arg-AMC (excitation 355 nm / emission 460 nm) with papain or cathepsin B at pH 6.0–6.5 in 100 mM sodium phosphate, 1 mM EDTA, 1 mM DTT is a practical starting point. Include a canonical cystatin C recombinant as a positive inhibition control to validate assay sensitivity before interpreting CSTL1-specific results.

What starting concentration of Cystatin Like 1 (Recombinant) should I use for a protease inhibition assay?

For initial dose-response experiments, test CSTL1 across a range of 0.1–10 µM against a fixed protease concentration (typically 2–5 nM papain or cathepsin B). Given that the Cres/Testatin subgroup can exhibit reduced inhibitory constants relative to canonical cystatins, err toward the higher end of this range for first-pass IC50 estimation. Dilute from the stock into assay buffer (100 mM sodium phosphate pH 6.0–6.5, 1 mM EDTA, 1 mM DTT) rather than directly into the storage buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol), as the glycerol content can affect fluorescence baselines at high concentrations.

How do I optimize buffer conditions when using Cystatin Like 1 (Recombinant) in a cysteine protease inhibition assay?

The storage buffer — 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol — is formulated for protein stability, not assay compatibility. For cysteine protease assays, keep the final glycerol contribution below 1% (v/v) by diluting at least 1:10 into assay buffer before adding to the reaction. Ensure DTT or TCEP (1–2 mM) is present to maintain protease active-site cysteines in a reduced state. If working at physiological pH (7.4), note that cathepsin B activity decreases substantially above pH 7.0; papain remains more active and is the preferred enzyme for neutral-pH inhibition screens.

Can I use Cystatin Like 1 (Recombinant) as a positive control for Western blot with the matched rabbit polyclonal antibody?

Yes — this is one of the primary use cases for REC-CystatinLike1. The matched antibody (SKU: RP-CystatinLike1; see /anti-cystatin-like-1-rabbit-polyclonal-antibody) is produced and validated in the same lab against CSTL1, and compatibility with this recombinant for Western blot is confirmed. Load 50–100 ng of recombinant protein per lane alongside your cell or tissue lysate. Expect a band in the 18–22 kDa range under reducing conditions. This side-by-side loading lets you confirm antibody sensitivity and confirm that a band in your lysate co-migrates with the correctly processed recombinant form.

How much recombinant Cystatin Like 1 should I load for Western blot positive control, and what antibody dilution works?

Load 50–100 ng per lane for a strong, clean signal with RP-CystatinLike1 on standard PVDF or nitrocellulose membranes. If you are titrating antibody concentration, 25 ng can still produce a detectable band at higher antibody concentrations. For the RP-CystatinLike1 rabbit polyclonal antibody (SKU: RP-CystatinLike1), a starting dilution of 1:500–1:2000 in 5% non-fat dry milk/TBST is a reasonable range; optimize for your specific lysate background. The recombinant's >90% purity by SDS-PAGE ensures the dominant band represents CSTL1, minimizing ambiguity in band assignment.

How should I store and handle Cystatin Like 1 (Recombinant) to maintain activity after arrival?

Store at -20°C immediately upon receipt. The protein is supplied in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol in single-use aliquots to eliminate repeated freeze-thaw cycles, which are the primary cause of activity loss in secreted cystatin-family proteins. Do not refreeze a thawed aliquot. For short-term bench use (same day), keep on ice; for use within 1–2 days, store the thawed aliquot at 4°C. Carrier protein (0.1% BSA) may be added if further dilutions below ~10 µg/mL are needed to reduce adsorptive losses on tube surfaces.

Validation imagery coming soon

Western blot validation figures for REC-CystatinLike1 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →